Mirati Therapeutics, Inc. (NASDAQ:MRTX) Expected to Post Quarterly Sales of $1.00 Million

Retrieved on: 2021-01-12 07:41:15

Tags for this article:

Click the tags to see associated articles and topics

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Expected to Post Quarterly Sales of $1.00 Million. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 3,449,202 shares of the biotechnology company's stock valued at $393,796,000 after acquiring an additional 45,764 ...

Article found on: www.marketbeat.com